Related Experiment Videos
Cipropride in preventing nausea and vomiting induced by severely emetic cytostatic agents
The Journal of International Medical Research
|January 1, 1981
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Half-Life and Precision Shape Measurement of the 2νββ Decay of ^{130}Te.
Physical review letters·2025
Search for Fractionally Charged Particles with CUORE.
Physical review letters·2025
Erratum: Measurement of the 2νββ Decay Half-Life of ^{130}Te with CUORE [Phys. Rev. Lett. 126, 171801 (2021)].
Physical review letters·2024
New Direct Limit on Neutrinoless Double Beta Decay Half-Life of ^{128}Te with CUORE.
Physical review letters·2022
Measurement of the 2νββ Decay Half-Life of ^{130}Te with CUORE.
Physical review letters·2021
Visual representation bias in artificial intelligence-generated depictions of anesthesia, pain, and intensive care professionals.
The Journal of international medical research·2026
Leukotrichia: A comprehensive review of follicular depigmentation.
The Journal of international medical research·2026
Variability in β-human chorionic gonadotropin concentrations following evacuation of a hydatidiform mole pregnancy: A retrospective cohort study from Vietnam.
The Journal of international medical research·2026
A single-cell atlas of peripheral immunity suggests immune subset attrition during tuberculosis dissemination.
The Journal of international medical research·2026
Clinical features of primary intestinal follicular lymphoma: A single-center retrospective study.
The Journal of international medical research·2026
Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.
Korean journal of radiology·2026
Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.
Transfusion medicine (Oxford, England)·2026